Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
spirulina liquid extract
- Development stage
- Unknown
- Lead developer
- Algosource
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Spirulina liquid extract (commercially known as Spirulysat) is a phycocyanin-rich aqueous extract derived from the cyanobacteria Arthrospira platensis (spirulina). Developed by AlgoSource, this liquid extract is highly concentrated in phycocyanin and polysaccharides, which provide potent antioxidant, anti-inflammatory, and metabolic-regulating properties. It has been clinically evaluated for its potential to alleviate oxidative stress, improve lipid and glucose metabolism, and protect against metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH). Additionally, a highly concentrated formulation of this extract (Phycocare) is being investigated in Phase II clinical trials for the prevention of chemotherapy-induced peripheral neuropathy (CIPN) in patients with gastrointestinal cancers.
- Brand names
- PhycocareSacred EssenceSpirulysatSpirulysat ConcentrateSpirulysat Original
- Other names
- Arthrospira liquid extractArthrospira platensis liquid extractSLEspirulina water extract
02
Targets
KEAP1 (Kelch-like ECH-associated protein 1)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)RELA (Nuclear Factor Kappa B Subunit p65)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on spirulina liquid extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on spirulina liquid extract.